73% of women over 40 ignore these symptoms, the study shows
A new study has shown that this health concern is not properly processed.
The last year was not the best with regard to our well-being. Beyond the obvious threat of Covid-itself, many of us haveLet our health take a back, be it because of the fear of contracting Covid to a doctor's office, high costs of health care or stress of discovering some bad news. A June 2020 survey of the Kaiser Family Foundation (KFF) found that almost half of the people in the United States - 48%.delayed medical care Because of the coronavirus, with 11% saying that their condition aggravated. But now that the pandemic becomes less worrying, there is little excuse for not having pain or pain that could be thesign of something more serious checked. Nevertheless, new research has found that manyWomen ignore symptoms a particular health problem. Read more about the condition not properly addressed by more than 70% of women.
RELATED:40 things that every woman over 40 should know about her health.
Nearly three-quarters of women over 40 do not know their symptoms of menopause.
New research of Bonafide, a company that sells women's health products, found that only the minority of women isTackle their symptoms of menopause. The company 2021 menopause study investigated more than 1,000 women aged 40 to 65 to the other from the United States according to the conclusions, 73% of women said they are not currently beingtreat their symptoms of menopause. This includes 16% that have hot flashes, 15% experiencing weight gain, 14% with sleeping difficulties and 14% with night sweats.
"Most women are lasting symptoms that can be chronic and in some progressive cases," says the authors of the study. "Physical symptoms have harmful consequences for health, not to mention the emotional toll of suffering (mainly) in silence."
Women also reduce drugs to treat menopause.
There has also been a steady decline in hormonal replacement therapy (HRTS), drugs thatContains female hormones To replace the estrogen that the body stops doing during menopause, by the Mayo Clinic. This medicine treats some of the most common menopausal symptoms, such as hot flashes. But according to the Mayo clinic, the HRTs do not come without risks - according to your age, your type of hormone therapy and your health history, you might be at risk of heart disease, stroke, blood clots and Breast cancer of the drug.
This may be the reason why many women do not use them anymore. According to Bonafide's study, 65% of women say they would not consider using HRTS to treat their menopause symptoms, despite 73% by saying that they are aware of the drug.
RELATED:For more information up to date, sign up for our daily newsletter.
Women are today "having a worst experience of menopause that their mothers", say the authors of the study.
Bonafide's study authors say the THRT market decreased by 94%. In their survey, 84% of the beneficiaries stated that they did not use the same menopausal treatments as their mother or grandmother used, and only 9% spoke to their mothers on the symptoms of menopause.
"Between the 1960s in the early 2000s, hormonal replacement therapy was the most common treatment of menopausal symptoms. It was also considered the most effective solution at the time," says the authors. "Since much less than women use the THS today, gaps always exist around effective substitution treatments, it is prudent to say that today's women have a worse menopause that their mother."
RELATED:50 signs of poor women should never ignore.
And many women have menopause symptoms that can last nearly ten years.
Research has shown that the symptoms of menopause can persist for nearly a decade for some women. A 2015 study published inJAMA internal medicine included around 1,500 women withFrequent vasomotor symptoms(VMS) of menopause, which includes hot flashes and night sweats. The researchers found that on average, more than half of the women studied had these symptoms for more than seven years and those who report the longest term had symptoms for more than 11 years.
"The total total median duration of 7.4 years highlights guidance limitations recommending short-term HT [hormone therapy therapy] and stresses the need to identify secure long-term therapies for the treatment of the VMS", explained The authors of the study.
